We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$2.5B
AUM Growth
+$144M
Cap. Flow
+$16.9M
Cap. Flow %
0.68%
Top 10 Hldgs %
23.95%
Holding
453
New
26
Increased
85
Reduced
124
Closed
20

Top Buys

1
LLY icon
Eli Lilly
LLY
+$23M
2
NVAX icon
Novavax
NVAX
+$18.4M
3
IQ icon
iQIYI
IQ
+$17.4M
4
CBOE icon
Cboe Global Markets
CBOE
+$17M
5
NFLX icon
Netflix
NFLX
+$16.8M

Top Sells

1
SRPT icon
Sarepta Therapeutics
SRPT
+$27.7M
2
ROKU icon
Roku
ROKU
+$20.6M
3
SPG icon
Simon Property Group
SPG
+$16.5M
4
NIO icon
NIO
NIO
+$15.7M
5
MRNA icon
Moderna
MRNA
+$13.5M

Sector Composition

1 Consumer Staples 21.66%
2 Healthcare 21%
3 Consumer Discretionary 11.38%
4 Communication Services 9.41%
5 Materials 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
151
Bristol-Myers Squibb
BMY
$124B
$477K 0.02%
7,134
-594
-8% -$38.7K
NEE icon
152
NextEra Energy
NEE
$185B
$477K 0.02%
6,504
-526
-7% -$39.5K
AG icon
153
First Majestic Silver
AG
$7.81B
$474K 0.02%
30,000
+2,574
+9% +$42.9K
AMGN icon
154
Amgen
AMGN
$198B
$449K 0.02%
1,841
-164
-8% -$40.3K
IBM icon
155
IBM
IBM
$200B
$449K 0.02%
3,207
– –
ORCL icon
156
Oracle
ORCL
$364B
$441K 0.02%
5,669
-512
-8% -$40.1K
QCOM icon
157
Qualcomm
QCOM
$181B
$422K 0.02%
2,952
-1,077
-27% -$146K
BRK.A icon
158
Berkshire Hathaway Class A
BRK.A
$1.06T
$419K 0.02%
1
– –
MSTR icon
159
Strategy Inc
MSTR
$34.4B
$411K 0.02%
+6,180
New +$366K
AMT icon
160
American Tower
AMT
$79.2B
$410K 0.02%
1,517
– –
GE icon
161
GE Aerospace
GE
$364B
$396K 0.02%
5,900
– –
MMM icon
162
3M
MMM
$83.4B
$391K 0.02%
2,355
– –
MKTX icon
163
MarketAxess Holdings
MKTX
$4.04B
$385K 0.02%
830
-761
-48% -$362K
NKE icon
164
Nike
NKE
$64.9B
$384K 0.02%
2,485
+536
+28% +$72.1K
CAT icon
165
Caterpillar
CAT
$405B
$378K 0.02%
1,735
-187
-10% -$43.2K
CVS icon
166
CVS Health
CVS
$137B
$374K 0.02%
4,478
– –
PLUG icon
167
Plug Power
PLUG
$3.03B
$370K 0.01%
10,808
-2,076
-16% -$60.2K
BKNG icon
168
Booking.com
BKNG
$141B
$306K 0.01%
3,500
– –
PEN icon
169
Penumbra
PEN
$12.5B
$305K 0.01%
1,113
+314
+39% +$85.7K
MDLZ icon
170
Mondelez International
MDLZ
$78.3B
$303K 0.01%
4,849
– –
AGNC icon
171
AGNC Investment
AGNC
$12.9B
$291K 0.01%
17,233
-7,832
-31% -$139K
ELV icon
172
Elevance Health
ELV
$80.9B
$289K 0.01%
757
-105
-12% -$40.1K
COP icon
173
ConocoPhillips
COP
$140B
$282K 0.01%
4,634
– –
FTCH
174
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$278K 0.01%
5,522
+767
+16% +$36.4K
ENPH icon
175
Enphase Energy
ENPH
$5.48B
$275K 0.01%
1,500
-2,200
-59% -$323K
5 6
7
8 9

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q2 2021 Portfolio in Review

As of Q2 2021, TOBAM held 453 positions worth $2.5B, up 6.1% from $2.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

TOBAM's Q2 2021 filing shows 26 new, 85 increased, 124 reduced and 20 closed positions. Its largest new stake was GFL Environmental: 313,947 shares worth $10M. The largest sale was Sarepta Therapeutics, an estimated $27.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • TOBAM's largest Q2 2021 buy was GFL Environmental: 313,947 shares worth $10M.
  • TOBAM added most to Eli Lilly in Q2 2021, an estimated $23M increase.
  • TOBAM's biggest Q2 2021 reduction was Roku, cutting an estimated $20.6M.
  • TOBAM fully exited Sarepta Therapeutics in Q2 2021, selling an estimated $27.7M.
  • TOBAM's ten largest holdings make up 24% of its $2.5B portfolio in Q2 2021.
  • TOBAM opened 26 new positions and closed 20 in Q2 2021.
  • TOBAM's portfolio value rose 6.1% quarter-over-quarter to $2.5B.

Based on TOBAM's 13F filing for Q2 2021, filed 11 Aug 2021.